Cargando…
Improved radiotracing of oxytocin receptor-expressing tumours using the new [(111)In]-DOTA-Lys(8)-deamino-vasotocin analogue
Oxytocin receptors (OTR) have been described in a number of tumours of different origin, and represent a new target for specific radiolabelled oxytocin (OT) analogues in cancer diagnosis and therapy. By linking the DOTA chelating agent to position 8 of the deamino derivative of Lys(8)-vasotocin (dLV...
Autores principales: | Chini, B, Chinol, M, Cassoni, P, Papi, S, Reversi, A, Areces, L, Marrocco, T, Paganelli, G, Manning, M, Bussolati, G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394487/ https://www.ncbi.nlm.nih.gov/pubmed/12942128 http://dx.doi.org/10.1038/sj.bjc.6601189 |
Ejemplares similares
-
Universal nomenclature for oxytocin–vasotocin ligand and receptor families
por: Theofanopoulou, Constantina, et al.
Publicado: (2021) -
Oxytocin and vasotocin receptor variation and the evolution of human prosociality
por: Theofanopoulou, Constantina, et al.
Publicado: (2022) -
[(111)In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study
por: Tatsi, Aikaterini, et al.
Publicado: (2012) -
Effect of Deamino-8-D-Arginine Desmopressin in Uremic Bleeding
por: Hong, Sae-Yong, et al.
Publicado: (1996) -
Arginine Vasotocin, the Social Neuropeptide of Amphibians and Reptiles
por: Wilczynski, Walter, et al.
Publicado: (2017)